Management of kidney disease on cancer chemotherapy with other drugs than platinum agents

Hideki Shimodaira

研究成果: Article

抜粋

Japanese clinical practice guidelines for the management of kidney disease in cancer survivors" have been published. This guideline recommended several managements for nephrotoxicity of other agents than platinum such as the urinary alkylation during methotrexate administration, suspending of anti-angiogenetic agent for the grade 2 or more proteinuria, dose modification of bisphosphonate based on the renal function. Understanding the background of these recommendations will contribute for safe cancer chemotherapy.

元の言語English
ページ(範囲)204-210
ページ数7
ジャーナルJapanese Journal of Cancer and Chemotherapy
44
発行部数3
出版物ステータスPublished - 2017 3 1

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

フィンガープリント Management of kidney disease on cancer chemotherapy with other drugs than platinum agents' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用